Trial Details
COMPLETEDBasic Information
| Clinical ID | c423 |
|---|---|
| Identifier | NCT05504915 |
| Trial Title | Real World Data on Vedolizumab Concentration and Outcomes in Inflammatory Bowel Disease (IBD) Patients Switching From Intravenous (IV) to Subcutaneous (SC) Vedolizumab in University Hospital Center Osijek |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Inflammatory Bowel Diseases|Crohn Disease|Colitis, Ulcerative |
| Interventions | - |
Participant Information
| Sponsor | Osijek University Hospital |
|---|---|
| City | Osijek |
| Country/Region | Croatia |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | OBSERVATIONAL |
|---|---|
| Phase | - |
Time Information
| Start Date | 2022-05-01 |
|---|---|
| Primary Completion Date | 2023-05-31 |
| Completion Date | 2023-05-31 |